Home › Upcoming votes › Tempest Therapeutics, Inc.
The deadline as the proxy statement states it: “vote is counted, your telephone vote must be received before 11:59 p.m., Eastern Time on November 8, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Tempest Therapeutics, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | Election of Class II directors Director election |
Board | For | 63% support for the one nominee |
| 2 | Ratification of Ernst & Young LLP as auditor Auditor |
Board | For | 83% support |
| 3 | Lincoln Park stock issuance (Nasdaq 5635(d)) | Board | For | — |
| 4 | Issuance of shares upon exercise of PIPE warrants (Nasdaq 5635(d)) | Board | — | — |
From Tempest Therapeutics, Inc.’s Form 8-K, filed January 28, 2026, for the meeting held January 27, 2026 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Geoff Nichol | 63% | — |
| 2. Approval, on an advisory basis, of the compensation of the Company's named executive officers | 66% | Approved |
| 3. Ratification of the Selection of Independent Registered Public Accounting Firm | 83% | Approved |
| 4. Approval of the Company's limited duration stockholder rights plan, as amended | 57% | Approved |
| 5. Approval of the issuance of the Company's common stock | 80% | Approved |
| 6. Approval of an amendment to the Company's Amended and Restated 2023 Equity Incentive Plan | 51.8% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.